Back to search
Scientific Name: Viloxazine
Brand Name: Qelbree
Company Owner: Not Available
Mechanism Of Action Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children characterized by inattention and hyperactivity. In current literature, the pathophysiology of ADHD is understood to involve the imbalance of neurotransmitters, especially dopamine (DA) and norepinephrine (NE) .
Description of the Drug: Viloxazine is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults in children.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from